Aspirin-Free Strategy is one of 2 therapeutic programs targeting Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI). It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Not yet recruiting
Competition
1 competitor in Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Aspirin-Free Strategy
Vicagrel
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details